Contento N, Paul D, Vates G, Johnson B, Brehm Z, Shafiq I
Pituitary. 2025; 28(2):35.
PMID: 40042661
DOI: 10.1007/s11102-025-01510-7.
Asa S, Ezzat S
Endocr Oncol. 2023; 2(1):R14-R23.
PMID: 37435449
PMC: 10259303.
DOI: 10.1530/EO-22-0041.
Asa S, Mete O, Cusimano M, McCutcheon I, Perry A, Yamada S
Mod Pathol. 2021; 34(9):1634-1650.
PMID: 34017065
DOI: 10.1038/s41379-021-00820-y.
Yang A, Cho S, Park H, Kim M, Kong D, Shin H
Front Endocrinol (Lausanne). 2020; 11:527.
PMID: 32849307
PMC: 7417303.
DOI: 10.3389/fendo.2020.00527.
Khalil H, Abdelnabi R, Osman A, Bashari W
Cureus. 2020; 12(7):e9043.
PMID: 32656046
PMC: 7346367.
DOI: 10.7759/cureus.9043.
Spontaneous Pituitary Adenomas in Squirrel Monkeys ().
Daggett G, Wood J, Gumber S, Pinelli C
Comp Med. 2019; 70(1):83-86.
PMID: 31747992
PMC: 7024770.
DOI: 10.30802/AALAS-CM-18-000137.
Invasive ACTH-secreting pituitary macroadenoma in remission after transsphenoidal resection: A case report and literature review.
Zhuang Z, Liu X, Bao X, Pan B, Deng K, Yao Y
Medicine (Baltimore). 2018; 97(46):e13148.
PMID: 30431585
PMC: 6257388.
DOI: 10.1097/MD.0000000000013148.
The impact on cognitive functions of patients with pituitary adenoma before and after surgery.
Wang X, Tong X, Zou Y, Tian X, Mao Z, Sun Z
Neurol Sci. 2017; 38(7):1315-1321.
PMID: 28478494
DOI: 10.1007/s10072-017-2980-z.
Medical management of functioning pituitary adenoma: an update.
Oki Y
Neurol Med Chir (Tokyo). 2014; 54(12):958-65.
PMID: 25446388
PMC: 4533360.
Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors.
Marko N, Hamrahian A, Weil R
Pituitary. 2010; 13(3):249-55.
PMID: 20339931
DOI: 10.1007/s11102-010-0227-6.
Mandibular prognathism caused by acromegaly - a surgical orthodontic case.
Gosau M, Vogel C, Moralis A, Proff P, Kleinheinz J, Driemel O
Head Face Med. 2009; 5:16.
PMID: 19660127
PMC: 2741435.
DOI: 10.1186/1746-160X-5-16.
Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1.
Sun C, Yamato T, Kondo E, Furukawa T, Ikeda H, Horii A
J Neurooncol. 2005; 73(2):131-4.
PMID: 15981102
DOI: 10.1007/s11060-004-4597-3.
Novel pituitary ligands: peroxisome proliferator activating receptor-gamma.
Heaney A
Pituitary. 2004; 6(3):153-9.
PMID: 14971739
DOI: 10.1023/b:pitu.0000011176.05771.46.
Quality of life in patients with a pituitary adenoma.
Johnson M, Woodburn C, Vance M
Pituitary. 2004; 6(2):81-7.
PMID: 14703017
DOI: 10.1023/b:pitu.0000004798.27230.ed.
Evaluation of modern pathologic nomenclature, tumor imaging and treatment of pituitary adenomas in a recent surgical series.
Cheung A, Sligh T, BAUSERMAN S, Schultz G
J Neurooncol. 1998; 37(2):145-53.
PMID: 9524093
DOI: 10.1023/a:1005957026287.
Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.
Thapar K, Kovacs K, Stefaneanu L, Scheithauer B, Killinger D, Lioyd R
Am J Pathol. 1997; 151(3):769-84.
PMID: 9284826
PMC: 1857857.
Failure in management of pituitary tumors discussion of 3 cases.
Sutter B, Steiner M, Lopes M, Prasad D, Steiner L
Acta Neurochir (Wien). 1995; 134(3-4):159-66.
PMID: 8748776
DOI: 10.1007/BF01417684.
Dopaminergic resistance in a case of invasive macroprolactinoma.
Schwarzstein D, Garcia-Patterson A, Gimenez G, Calaf J, Puig-Domingo M, Caixas A
J Endocrinol Invest. 1993; 16(6):443-7.
PMID: 8103781
DOI: 10.1007/BF03348879.
Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
Blanco C, Lucas T, Alcaniz J, Davila N, Serrano P, Barcelo B
J Endocrinol Invest. 1994; 17(2):99-104.
PMID: 8006339
DOI: 10.1007/BF03347693.
Pituitary tumors. Current concepts in diagnosis and management.
Aron D, Tyrrell J, Wilson C
West J Med. 1995; 162(4):340-52.
PMID: 7747500
PMC: 1022773.
